203 related articles for article (PubMed ID: 10969804)
1. p53 dependence of topoisomerase I recruitment in vivo.
Mao Y; Okada S; Chang LS; Muller MT
Cancer Res; 2000 Aug; 60(16):4538-43. PubMed ID: 10969804
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
Nip J; Hiebert SW
Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
[TBL] [Abstract][Full Text] [Related]
3. Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53.
Cowell IG; Okorokov AL; Cutts SA; Padget K; Bell M; Milner J; Austin CA
Exp Cell Res; 2000 Feb; 255(1):86-94. PubMed ID: 10666337
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas.
Coleman LW; Bronstein IB; Holden JA
Anticancer Res; 2001; 21(2A):1167-72. PubMed ID: 11396158
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
Satterwhite DJ; White RL; Matsunami N; Neufeld KL
Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.
van der Zee AG; de Jong S; Keith WN; Hollema H; Boonstra H; de Vries EG
Cancer Res; 1994 Feb; 54(3):749-55. PubMed ID: 8306337
[TBL] [Abstract][Full Text] [Related]
7. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
Constantinou AI; Vaughan AT; Yamasaki H; Kamath N
Cancer Res; 1996 Sep; 56(18):4192-9. PubMed ID: 8797591
[TBL] [Abstract][Full Text] [Related]
8. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.
Kim HD; Tomida A; Ogiso Y; Tsuruo T
J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022
[TBL] [Abstract][Full Text] [Related]
9. How do drug-induced topoisomerase I-DNA lesions signal to the molecular interaction network that regulates cell cycle checkpoints, DNA replication, and DNA repair?
Kohn KW; Shao RG; Pommier Y
Cell Biochem Biophys; 2000; 33(2):175-80. PubMed ID: 11325037
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
11. Human ARF protein interacts with topoisomerase I and stimulates its activity.
Karayan L; Riou JF; Séité P; Migeon J; Cantereau A; Larsen CJ
Oncogene; 2001 Feb; 20(7):836-48. PubMed ID: 11314011
[TBL] [Abstract][Full Text] [Related]
12. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
Staley BE; Samowitz WS; Bronstein IB; Holden JA
Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
[TBL] [Abstract][Full Text] [Related]
13. Modulation of DNA topoisomerase I activity by p53.
Gobert C; Bracco L; Rossi F; Olivier M; Tazi J; Lavelle F; Larsen AK; Riou JF
Biochemistry; 1996 May; 35(18):5778-86. PubMed ID: 8639538
[TBL] [Abstract][Full Text] [Related]
14. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
[TBL] [Abstract][Full Text] [Related]
15. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
Tomicic MT; Christmann M; Kaina B
Cancer Res; 2005 Oct; 65(19):8920-6. PubMed ID: 16204064
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair.
Subramanian D; Rosenstein BS; Muller MT
Cancer Res; 1998 Mar; 58(5):976-84. PubMed ID: 9500459
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro.
Søe K; Hartmann H; Schlott B; Stevnsner T; Grosse F
Oncogene; 2002 Sep; 21(43):6614-23. PubMed ID: 12242659
[TBL] [Abstract][Full Text] [Related]
18. Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers.
Kim R; Ohi Y; Inoue H; Toge T
Anticancer Res; 1999; 19(6B):5393-8. PubMed ID: 10697567
[TBL] [Abstract][Full Text] [Related]
19. Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.
López-Lázaro M; Willmore E; Jobson A; Gilroy KL; Curtis H; Padget K; Austin CA
J Nat Prod; 2007 Dec; 70(12):1884-8. PubMed ID: 18076140
[TBL] [Abstract][Full Text] [Related]
20. Cells lacking DNA topoisomerase II beta are resistant to genistein.
López-Lazaro M; Willmore E; Austin CA
J Nat Prod; 2007 May; 70(5):763-7. PubMed ID: 17411092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
